Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Tax Rate (2016 - 2025)

Historic Tax Rate for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to 44.32%.

  • Zevra Therapeutics' Tax Rate changed N/A to 44.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 34.15%, marking a year-over-year change of. This contributed to the annual value of 17.05% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Zevra Therapeutics reported Tax Rate of 44.32% as of Q3 2025.
  • Zevra Therapeutics' Tax Rate's 5-year high stood at 44.32% during Q3 2025, with a 5-year trough of 75.47% in Q4 2024.
  • Its 5-year average for Tax Rate is 7.45%, with a median of 0.19% in 2022.
  • Its Tax Rate has fluctuated over the past 5 years, first soared by 58400bps in 2023, then crashed by -620800bps in 2025.
  • Zevra Therapeutics' Tax Rate (Quarter) stood at 1.27% in 2021, then tumbled by -854bps to 12.15% in 2022, then surged by 86bps to 1.74% in 2023, then tumbled by -4245bps to 75.47% in 2024, then surged by 159bps to 44.32% in 2025.
  • Its Tax Rate was 44.32% in Q3 2025, compared to 2.86% in Q2 2025 and 61.66% in Q1 2025.